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Patients with primary adenocarcinoma of the jejunum are very rare1), and there has 
been no report to our knowledge showing how nuclear medicine techniques may play a role 
in diagnosis.  We have experienced a case of an advanced adenocarcinoma of the jejunum 
with distant metastatases, for which positron emission tomography (PET) with fluorine-18 
2-deoxy-2-fluoro-D-glucose (FDG) and gallium-67 citrate scintigraphy were compared.   
 
A Case Report 
A 70-year-old woman was referred to our institute because of an adenocarcinoma 
metastasis to cervical lymph node with unknown primary lesion.   
She had found painlessly swelling in her left cervical lymph nodes three months 
previously and visited her local hospital.  Biopsy revealed metastases from an 
adenocarcinoma and a series of investigations were carried out to find the primary site but 
failed.   
When she visited our institute, she presented no symptoms except for swollen 
cervical lymph nodes and her laboratory data were unremarkable.  Gastroduodenal and 
colonic endoscopies were carried out but the original site was undetected.  Computed 
tomography (CT) scanned the whole body and revealed the right cervical lymph nodes and 
para-abdominal aortic lymph nodes and retro-pancreatic lymph node to be swollen (Fig 1).  
Gallium scintigraphy was carried out and abnormal accumulations in the left cervix, left 
axillary and the center of the abdomen could be visualized (Fig. 2b).  When CT scan 
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images were checked retrospectively, the lymph nodes in the left axillary were found to be 
swollen (Fig. 1).   
As the next step for diagnosis, FDG PET was carried out and showed accumulation 
corresponding to all of the swollen lymph nodes and the small intestine (Fig 3).  
According to these findings, the barium meal fluoroscopy of the small intestine was carried 
out and showed a defective image near the angle of Treitz (Fig.4).  From these findings, 
the horizontal portion of the duodenum or the jejunum was suspected as the primary site.  
A gastroduodenal endoscope was therefore introduced into the deep horizontal portion of 
the duodenum, and a Bormann type II tumor were found.  A biopsy was carried out and 
the histological examination revealed an adenocarcinoma. 
Two weeks thereafter, partial resection of jejunum was performed due to the risk of 
the obstruction and bleeding, and clarified the existence of a Bormann type II tumor, a 
moderately differentiated adenocarcinoma of the jejunum, 5 cm to the anal side of the Treiz 
ligament.   
 
Discussion 
Small intestinal adenocarcinomas are very rare, accounting for only 2% of 
gastrointestinal tumors1).  In 4995 cases reported to the National Cancer Data Base 
between 1985 and 1995, 55% of them occurred in the duodenum, 18% in the jejunum, 13% 
in the ileum and 14% in nonspecified sites2).  There are no specific symptoms and 
diagnosis is frequently very late at an advanced stage.  Most common symptoms are pain 
due to obstruction, weight loss and massive and occult hemorrhage3).  In our case, cervical 
lymph nodes were found to be swollen at first and in the search for the primary site, a 
jejunal adenocarcinoma was diagnosed.   
FDG PET is a noninvasive approach for determination of glycolytic status.  PET is 
able to make an image that shows the tissue distribution of FDG, a structural analog of 
glucose labeled with the short-lived positron-emitting 18F4).  FDG is transported into the 
cell via a glucose-transporter, then is converted to FDG-6-phosphate by hexokinase in cells, 
but it is not a substrate for further metabolism, nor permeable to the cell membrane, and 
therefore accumulates within the cell5).  Enhanced glycolysis is one of the most important 
characteristics of cancer cells6), and FDG PET has proved successful for imaging various 
malignant neoplasms7).  In our case, FDG PET could detect the primary lesion and 
apparently all of the metastastic lesions.  Koles et al.8) and Bohuslavizki et al.9) reported 
that FDG PET is a valuable diagnostic tool in patients with cancer of unknown primary.  
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In our case, FDG PET is also helpful to find the primary lesion.  This is the first report of 
FDG PET imaging of a jejunal adenocarcinoma, providing support for the conclusion that 
this approach can greatly contribute to the differential diagnosis of primary lesions in 
patients with metastatic lymph node deposits.  The final diagnosis can then be made on 
histological examination after endoscopic sampling, advised here.   
Gallium scintigraphy was also carried out in our case and succeeded in detecting 
another lymph node metastasis in the upper body.  However, it failed to detect lesions in 
the abdomen, presumably due to the physiological accumulation of gallium in the liver and 
the excretion with bile juice into the bowel10).   
In conclusion, FDG PET should prove helpful in the diagnosis of the small 
intestinal adenocarcinomas with metastases.   
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Fig. 1.  CT images show lymph nodes swelling in; a: left cervical lymph nodes.  b: the left axillary lymph 




Fig. 2.  Gallium scintigraphy shows abnormal accumulations in the left cervix (arrow (a)), left axillary 
(arrow (b)), and the center of the abdomen (arrow (c)).   
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Fig. 3.  The image of FDG PET has accumulations corresponding to all lesions.  The arrow (d) indicates the 
slightly high accumulation of FDG that is thought to be corresponding to the primary lesion.  All other high 
accumulations of FDG are corresponding to the metastatic lesions in; a: the cervical lymph nodes.  b: the 





Fig. 4.  The barium meal fluoroscopy of the small intestine shows a defective image near the angle of Treitz.  
a: the image of the whole.  B: the enlarged and pressured image of the lesion suspected as a primary lesion.  
Arrows indicate the lesion.  
